Desarrollo de Vacunas
French Institute of Health and Medical Research
París, FranciaFrench Institute of Health and Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2012
-
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
Vaccine, Vol. 30, Núm. 18, pp. 2848-2858
-
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
International Journal of Cancer, Vol. 131, Núm. 3, pp. 641-651
2011
-
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10
Hepatology, Vol. 53, Núm. 1, pp. 23-31
2010
-
Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis
Vaccine, Vol. 28, Núm. 44, pp. 7146-7154
2007
-
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo
Journal of Immunology, Vol. 178, Núm. 2, pp. 748-756